Clinical Trial Update: Serum Biomarker Levels Improvement in Poly Cystic Ovarian Syndrome: Impact of Metformin Compared to Healthy Controls [NA]

View source ↗

Summary

A completed clinical trial reports improvements in serum biomarker levels in polycystic ovary syndrome and compares metformin effects to healthy controls.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Polycystic Ovary Syndrome

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Aga Khan University | Conditions: Polycystic Ovary Syndrome, Insulin Resistance | NA | Status: COMPLETED